Targeting Telomerase Cajal Body Protein 1 (TCAB1) as a Novel Strategy for Discovering Potent Telomerase Inhibitors That Enhance Antitumor Immunity.
- DOI
- 10.1021/acs.jmedchem.6c00753
- Published
- 2026 Aug 13
- Container
- Journal of medicinal chemistry
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1021/acs.jmedchem.6c00753,
title = {Targeting Telomerase Cajal Body Protein 1 (TCAB1) as a Novel Strategy for Discovering Potent Telomerase Inhibitors That Enhance Antitumor Immunity.},
author = {Zuo H and Gao X and Wang Y and Yan Y and Ru Y and Zhao J and Chen X and Zhang Y and Ma X and Liu X and Wang Y},
year = {2026},
journal = {Journal of medicinal chemistry},
doi = {10.1021/acs.jmedchem.6c00753},
url = {https://doi.org/10.1021/acs.jmedchem.6c00753}
}RIS
TY - JOUR TI - Targeting Telomerase Cajal Body Protein 1 (TCAB1) as a Novel Strategy for Discovering Potent Telomerase Inhibitors That Enhance Antitumor Immunity. AU - Zuo H AU - Gao X AU - Wang Y AU - Yan Y AU - Ru Y AU - Zhao J AU - Chen X AU - Zhang Y AU - Ma X AU - Liu X AU - Wang Y PY - 2026 JO - Journal of medicinal chemistry DO - 10.1021/acs.jmedchem.6c00753 UR - https://doi.org/10.1021/acs.jmedchem.6c00753 ER -
APA
H, Z., X, G., Y, W., Y, Y., Y, R., J, Z., X, C., Y, Z., X, M., X, L., & Y, W. (2026). Targeting Telomerase Cajal Body Protein 1 (TCAB1) as a Novel Strategy for Discovering Potent Telomerase Inhibitors That Enhance Antitumor Immunity.. Journal of medicinal chemistry. https://doi.org/10.1021/acs.jmedchem.6c00753
Source records
- pubmed · retrieved 2026-09-26T04:07:09.979Z